Wells Fargo Lowers its Price Target on Universal Health Services, Inc. (UHS) to $212 and Maintains an Equal Weight Rating

Universal Health Services, Inc. (NYSE:UHS) is among the 11 Cheap Growth Stocks to Buy Right Now.

Wells Fargo Lowers its Price Target on Universal Health Services, Inc. (UHS) to $212 and Maintains an Equal Weight Rating

On March 2, 2026, Wells Fargo lowered the price target on Universal Health Services, Inc. (NYSE:UHS) to $212 from $235 previously and maintained an Equal Weight rating. Wells Fargo said Q4 results were weak, primarily due to the Acute business. Wells Fargo added that 2026 guidance is in line with consensus but will require stronger volumes and core growth than seen in 2025.

On February 26, 2026, Barclays raised its price target on Universal Health Services, Inc. (NYSE:UHS) to $268 from $262 previously and maintained an Overweight rating following the Q4 report. Barclays said the company posted a modest miss as acute volumes decelerated but still guided 2026 EBITDA ahead of Street estimates.

On February 25, 2026, Universal Health Services, Inc. (NYSE:UHS) reported fourth-quarter EPS of $5.88 versus consensus of $5.90 and revenue of $4.49B compared with consensus of $4.5B. The company expects FY26 adjusted EPS of $22.64-$24.52 compared with the consensus of $23.52.

Universal Health Services, Inc. (NYSE:UHS) owns and operates acute care hospitals and outpatient and behavioral health care facilities in the United States through its Acute Care Hospital Services and Behavioral Health Care Services segments.

While we acknowledge the potential of UHS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UHS and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026

Disclosure: None. Follow Insider Monkey on Google News.